Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Sullivan

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|July 15, 1999
Regulation of endothelial cell adherens junctions by a Ras-dependent signal transduction pathwayD D Hegland, D M Sullivan, I I Rovira, et al.
Cancer Research|April 15, 1995
Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell lineW G Harker, D L Slade, R L Parr, et al.
International Psychogeriatrics|March 27, 2001
Identifying dementia in the primary care practiceP R Solomon, M Brush, V Calvo, et al.
International Journal of Cancer|May 16, 1996
Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceB W Futscher, N E Foley, M C Gleason-Guzman, et al.
Human Gene Therapy|December 31, 1997
Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patientsT G Jensen, D M Sullivan, R A Morgan, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and betaR M Turnbull, E L Meczes, M Perenna Rogers, et al.
Journal of Cellular Biochemistry|September 29, 1999
Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell linesD Hochhauser, N I Valkov, J L Gump, et al.
Human Gene Therapy|June 13, 1998
Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma modelJ G Turner, J Tan, B E Crucian, et al.
Molecular Pharmacology|February 1, 1993
Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell lineD M Sullivan, L A Eskildsen, K R Groom, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapyC E Parr, D M Sullivan, A M Paradiso, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|July 15, 1999
Regulation of endothelial cell adherens junctions by a Ras-dependent signal transduction pathwayD D Hegland, D M Sullivan, I I Rovira, et al.
Cancer Research|April 15, 1995
Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell lineW G Harker, D L Slade, R L Parr, et al.
International Psychogeriatrics|March 27, 2001
Identifying dementia in the primary care practiceP R Solomon, M Brush, V Calvo, et al.
International Journal of Cancer|May 16, 1996
Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceB W Futscher, N E Foley, M C Gleason-Guzman, et al.
Human Gene Therapy|December 31, 1997
Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patientsT G Jensen, D M Sullivan, R A Morgan, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and betaR M Turnbull, E L Meczes, M Perenna Rogers, et al.
Journal of Cellular Biochemistry|September 29, 1999
Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell linesD Hochhauser, N I Valkov, J L Gump, et al.
Human Gene Therapy|June 13, 1998
Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma modelJ G Turner, J Tan, B E Crucian, et al.
Molecular Pharmacology|February 1, 1993
Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell lineD M Sullivan, L A Eskildsen, K R Groom, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapyC E Parr, D M Sullivan, A M Paradiso, et al.
Pageof 8